Page last updated: 2024-10-24

carmustine and Esotropia

carmustine has been researched along with Esotropia in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Esotropia: A form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a cross-eye appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vincent, FM1

Other Studies

1 other study available for carmustine and Esotropia

ArticleYear
Spinal leptomeningeal invasion from intracranial glioblastoma multiforme.
    Archives of physical medicine and rehabilitation, 1983, Volume: 64, Issue:1

    Topics: Brain Neoplasms; Carmustine; Cauda Equina; Cerebrospinal Fluid; Child, Preschool; Cobalt Radioisotop

1983